Antiadenovirus drug discovery: potential targets and evaluation methodologies

Area of Science:

• Virology
• Infectious Diseases
• Drug Discovery

Background:

• Human adenoviruses (HAdV) are common viral pathogens responsible for a range of acute infections, including respiratory, gastrointestinal, and ocular diseases.
• While typically self-limiting in immunocompetent individuals, HAdV infections pose a serious threat, leading to high morbidity and mortality in immunocompromised populations, especially children.
• The absence of approved antiviral treatments for HAdV infections highlights a critical unmet medical need.

Purpose of the Study:

• To provide a comprehensive overview of potential therapeutic targets for antiviral drug development against HAdV.
• To review the existing in vitro and in vivo methodologies for screening and evaluating novel anti-HAdV drug candidates.

Main Methods:

• Literature review and synthesis of current research on HAdV biology and antiviral strategies.
• Analysis of established and emerging drug targets within the HAdV life cycle.
• Evaluation of in vitro and in vivo models for assessing antiviral efficacy.

Main Results:

• Identified key viral proteins and processes as potential targets for antiviral intervention.
• Summarized various screening platforms, including cell-based assays and animal models.
• Highlighted the challenges and opportunities in developing specific anti-HAdV therapeutics.

Conclusions:

• Targeting specific viral components offers a promising avenue for developing effective HAdV antiviral therapies.
• Robust screening tools are essential for the efficient identification and validation of candidate antiviral molecules.
• Further research and development are crucial to address the clinical burden of HAdV infections.